Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Akseli Hemminki

Showing results (1-10 of 280) with videos related to

Pageof 28
Sort By:
Human Vaccines & Immunotherapeutics|August 24, 2012
Portrait of a leader in immunotherapeutics: oncolytic viruses for treatment of cancerAkseli Hemminki
Scientifica|February 20, 2014
Oncolytic immunotherapy: where are we clinically?Akseli Hemminki
Annals of Medicine|May 21, 2005
Adenoviruses for treatment of cancerAnna Kanerva, Akseli Hemminki
Expert Opinion on Biological Therapy|May 25, 2004
Tissue-specific promoters for cancer gene therapyKirsi Saukkonen, Akseli Hemminki
International Journal of Cancer|May 4, 2004
Modified adenoviruses for cancer gene therapyAnna Kanerva, Akseli Hemminki
Current Gene Therapy|April 9, 2008
Virotherapy as an approach against cancer stem cellsCamilla Ribacka, Akseli Hemminki
Viruses|October 14, 2011
Serotype chimeric human adenoviruses for cancer gene therapyTuuli Ranki, Akseli Hemminki
Biodrugs : Clinical Immunotherapeutics, Biopharmaceuticals and Gene Therapy|May 3, 2002
Adenoviruses in oncology: a viable option?Akseli Hemminki, Ronald D Alvarez
BMJ Open Gastroenterology|July 17, 2021
Survival in colon and rectal cancers in Finland and Sweden through 50 yearsKari Hemminki, Asta Försti, Akseli Hemminki
Current Opinion in Molecular Therapeutics|October 8, 2004
Multicellular tumor spheroids in gene therapy and oncolytic virus therapyMartine L M Lamfers, Akseli Hemminki
Pageof 28

Showing results (1-10 of 280) with videos related to

Sort By:
Pageof 28
Human Vaccines & Immunotherapeutics|August 24, 2012
Portrait of a leader in immunotherapeutics: oncolytic viruses for treatment of cancerAkseli Hemminki
Scientifica|February 20, 2014
Oncolytic immunotherapy: where are we clinically?Akseli Hemminki
Annals of Medicine|May 21, 2005
Adenoviruses for treatment of cancerAnna Kanerva, Akseli Hemminki
Expert Opinion on Biological Therapy|May 25, 2004
Tissue-specific promoters for cancer gene therapyKirsi Saukkonen, Akseli Hemminki
International Journal of Cancer|May 4, 2004
Modified adenoviruses for cancer gene therapyAnna Kanerva, Akseli Hemminki
Current Gene Therapy|April 9, 2008
Virotherapy as an approach against cancer stem cellsCamilla Ribacka, Akseli Hemminki
Viruses|October 14, 2011
Serotype chimeric human adenoviruses for cancer gene therapyTuuli Ranki, Akseli Hemminki
Biodrugs : Clinical Immunotherapeutics, Biopharmaceuticals and Gene Therapy|May 3, 2002
Adenoviruses in oncology: a viable option?Akseli Hemminki, Ronald D Alvarez
BMJ Open Gastroenterology|July 17, 2021
Survival in colon and rectal cancers in Finland and Sweden through 50 yearsKari Hemminki, Asta Försti, Akseli Hemminki
Current Opinion in Molecular Therapeutics|October 8, 2004
Multicellular tumor spheroids in gene therapy and oncolytic virus therapyMartine L M Lamfers, Akseli Hemminki
Pageof 28